Michele Di Martino
Overview
Explore the profile of Michele Di Martino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DErasmo L, Di Martino M, Neufeld T, Fraum T, Kang C, Burks K, et al.
Circulation
. 2023 Sep;
148(19):1479-1489.
PMID: 37712257
Background: ANGPTL3 (angiopoietin-like 3) is a therapeutic target for reducing plasma levels of triglycerides and low-density lipoprotein cholesterol. A recent trial with vupanorsen, an antisense oligonucleotide targeting hepatic production of...
2.
Polti G, Frigerio F, Del Gaudio G, Pacini P, Dolcetti V, Renda M, et al.
Pediatr Radiol
. 2023 Sep;
53(12):2458-2465.
PMID: 37698614
Background: Biopsy remains the gold standard for the diagnosis of hepatic steatosis, the leading cause of pediatric chronic liver disease; however, its costs call for less invasive methods. Objective: This...
3.
Kalshabay Y, Zholdybay Z, Di Martino M, Medeubekov U, Baiguissova D, Ainakulova A, et al.
Insights Imaging
. 2023 May;
14(1):82.
PMID: 37184628
Objectives: The aim of this retrospective study is to compare and evaluate accuracy of three different approaches of liver volume quantification in living donor transplantations. Methods: This is a single-center,...
4.
Brozzetti S, DAlterio C, Bini S, Antimi J, Rocco B, Fassari A, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139581
Hepatocellular carcinoma (HCC) usually develops in cirrhotic liver, with high recurrence rates. However, considering its increasing detection in non-cirrhotic liver, the choice of treatment assumes particular relevance. This study aimed...
5.
Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, Di Martino M, et al.
Dig Liver Dis
. 2022 Jan;
54(8):1060-1065.
PMID: 35058135
Introduction/aim: Muscle alterations, portosystemic shunts (SPSS) and minimal hepatic encephalopathy (MHE) are related to hepatic encephalopathy (HE), however no studies have investigated the relative role of all these risk factors...
6.
Parisse S, Ferri F, Persichetti M, Mischitelli M, Abbatecola A, Di Martino M, et al.
Sci Rep
. 2021 Jul;
11(1):15184.
PMID: 34312420
This study aimed to ascertain, for the first time, whether serum magnesium (Mg) concentration is affected by the presence of hepatocellular carcinoma (HCC). We retrospectively enrolled consecutive cirrhotic patients with...
7.
Brozzetti S, Tancredi M, Bini S, de Lucia C, Antimi J, DAlterio C, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34204186
Hepatocellular carcinoma (HCC) accounts for 75-85% of primary liver malignancies, and elderlies have the highest incidence rates. Direct-acting antiviral agents (DAAs) have shown satisfying results in terms of HCV sustained...
8.
Lai Q, Magistri P, Lionetti R, Avolio A, Lenci I, Giannelli V, et al.
Liver Int
. 2021 Apr;
41(7):1629-1640.
PMID: 33793054
Background & Aims: Sarcopenia in liver transplantation (LT) cirrhotic candidates has been connected with higher dropouts and graft losses after transplant. The study aims to create an 'urgency' model combining...
9.
Nardelli S, Riggio O, Turco L, Gioia S, Puzzono M, Bianchini M, et al.
Radiology
. 2021 Feb;
299(1):133-140.
PMID: 33529134
Background Cirrhosis leads to portal hypertension and to the consequent formation of spontaneous portosystemic shunts (SPSSs), leading to complications related to the diversion of portal blood into the systemic circulation,...
10.
Di Costanzo A, Ronca A, DErasmo L, Manfredini M, Baratta F, Pastori D, et al.
Biomedicines
. 2020 Dec;
8(12).
PMID: 33352841
. Non-alcoholic fatty liver disease (NAFLD) increases the risk of atherosclerosis but this risk may differ between metabolically- vs. genetically-driven NAFLD. High-density lipoprotein (HDL)-mediated cholesterol efflux (CEC) and plasma loading...